Product Code: ETC11831897 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Cell Gene Therapy Clinical Trial Services Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Cell Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 Mexico Cell Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Cell Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell gene therapy research and development in Mexico |
4.2.2 Growing prevalence of genetic disorders and chronic diseases driving demand for clinical trials |
4.2.3 Favorable regulatory environment supporting cell gene therapy clinical trials in Mexico |
4.3 Market Restraints |
4.3.1 High cost of cell gene therapy clinical trials may hinder market growth |
4.3.2 Limited expertise and infrastructure for conducting advanced clinical trials in Mexico |
5 Mexico Cell Gene Therapy Clinical Trial Services Market Trends |
6 Mexico Cell Gene Therapy Clinical Trial Services Market, By Types |
6.1 Mexico Cell Gene Therapy Clinical Trial Services Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Preclinical Research Services, 2021 - 2031F |
6.1.4 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Clinical Trial Management, 2021 - 2031F |
6.1.5 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment Services, 2021 - 2031F |
6.1.6 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Biomarker Analysis Services, 2021 - 2031F |
6.2 Mexico Cell Gene Therapy Clinical Trial Services Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By In-Vivo and In-Vitro Models, 2021 - 2031F |
6.2.3 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Data Analytics and AI Integration, 2021 - 2031F |
6.2.4 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By AI-Powered Patient Matching, 2021 - 2031F |
6.2.5 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.3 Mexico Cell Gene Therapy Clinical Trial Services Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Academic Research Centers, 2021 - 2031F |
6.3.3 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By CROs and Pharma Companies, 2021 - 2031F |
6.3.4 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Hospitals and Clinics, 2021 - 2031F |
6.3.5 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Biotech Startups, 2021 - 2031F |
6.4 Mexico Cell Gene Therapy Clinical Trial Services Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Proof-of-Concept Studies, 2021 - 2031F |
6.4.3 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Compliance, 2021 - 2031F |
6.4.4 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Enrolling Patients for CGT Trials, 2021 - 2031F |
6.4.5 Mexico Cell Gene Therapy Clinical Trial Services Market Revenues & Volume, By Personalized Cell and Gene Therapies, 2021 - 2031F |
7 Mexico Cell Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 Mexico Cell Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 Mexico Cell Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 Mexico Cell Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Number of new cell gene therapy clinical trials initiated in Mexico |
8.2 Percentage increase in funding allocated to cell gene therapy research in Mexico |
8.3 Number of partnerships formed between local research institutions and international biotech companies. |
9 Mexico Cell Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 Mexico Cell Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Mexico Cell Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 Mexico Cell Gene Therapy Clinical Trial Services Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mexico Cell Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Cell Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 Mexico Cell Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 Mexico Cell Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |